ArticleBMC pediatrics2025
From cultural remedy to medical emergency: a case report of camphor toxicity in a one-year-old male patient.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCamphor (CMP) is widely used for cultural and medicinal purposes in regions like the Middle East, India, Nigeria, and Latin America. Despite its traditional uses, CMP presents serious toxic risks, particularly in infants and children, where even small ingested doses can lead to life-threatening symptoms. This case report highlights the risk posed by camphor ingestion in a pediatric patient, emphasizing its relevance to healthcare providers in regions where camphor is commonly used. CASE PRESENTATION: A one-year-old male was admitted to the Dr. Hugo Mendoza Pediatric Hospital in Santo Domingo, Dominican Republic, after ingesting camphor tablets. He presented in a postictal state following generalized tonic-clonic seizures at home, with further seizures occurring in the hospital. The seizures were controlled with intravenous diazepam, and diagnostic tests, including a head CT scan, revealed no significant abnormalities. The patient received supportive care, including levetiracetam for seizure control, and was monitored in the pediatric intensive care unit. After clinical improvement, he was transferred to the general pediatric unit without further complications.
conclusionsThis case highlights the dangers of camphor exposure, particularly in young children, and the need for healthcare providers to consider CMP poisoning in cases of unexplained seizures. It also underscores the importance of educating parents about the safe storage of camphor-containing products. Further research is needed to explore the long-term effects of camphor toxicity and develop effective public health measures to prevent such poisonings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.